Lingxi Jiang
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 detection and testing
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Ubiquitin and proteasome pathways 3
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
- Oncology 11
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Chunbao Xie (9 shared papers)Zhenglin Yang (7 shared papers)Bo Gong (8 shared papers)Yi Shi (6 shared papers)Hong Pu (1 shared paper)Guo Huang (1 shared paper)Hua Yu (1 shared paper)Xuemei Chen (1 shared paper)
In The Last Decade
Lingxi Jiang
50 papers receiving 804 citations
Peers
Comparison fields: 5 of 110
- Infectious Diseases 181
- Cancer Research 78
- Oncology 117
- General Dentistry 6
- Molecular Biology 269
Countries citing papers authored by Lingxi Jiang
This map shows the geographic impact of Lingxi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingxi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingxi Jiang more than expected).
Fields of papers citing papers by Lingxi Jiang
This network shows the impact of papers produced by Lingxi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingxi Jiang. The network helps show where Lingxi Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingxi Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 255 | |
| 2 | 2022 | 84 | |
| 3 | 2023 | 52 | |
| 4 | 2021 | 32 | |
| 5 | 2021 | 30 | |
| 6 | 2020 | 27 | |
| 7 | 2019 | 25 | |
| 8 | 2010 | 24 | |
| 9 | 2021 | 22 | |
| 10 | 2022 | 20 | |
| 11 | 2023 | 20 | |
| 12 | 2012 | 19 | |
| 13 | 2022 | 18 | |
| 14 | 2010 | 15 | |
| 15 | 2023 | 14 | |
| 16 | 2009 | 13 | |
| 17 | 2023 | 11 | |
| 18 | 2023 | 11 | |
| 19 | 2024 | 10 | |
| 20 | 2022 | 10 |
About Lingxi Jiang
Lingxi Jiang is a scholar working on Molecular Biology, Oncology, Epidemiology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering, having authored 53 papers that have together received 815 indexed citations. Recurring topics across this work include Ophthalmology and Visual Impairment Studies (6 papers), Nanoplatforms for cancer theranostics (4 papers), Ubiquitin and proteasome pathways (3 papers), Epigenetics and DNA Methylation (3 papers), Genetically Modified Organisms Research (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Retinal Diseases and Treatments (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Infectious Diseases (181 citations), Cancer Research (78 citations), Oncology (117 citations), General Dentistry (6 citations) and Molecular Biology (269 citations). Lingxi Jiang has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Chunbao Xie, Zhenglin Yang, Bo Gong, Yi Shi, Hong Pu, Guo Huang, Hua Yu, Xuemei Chen, He Lin and Guo Si. Their work appears in journals such as Advanced Science, Ophthalmic Genetics, Advanced Materials, Journal of Experimental & Clinical Cancer Research and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.